AI Meets RNA: Atomic AI's Revolutionary Drug Discovery Strategy

Send us a text

In this episode of the Life Science Success Podcast my guest is Mark Stead, Head of Business Development at Atomic AI, a pioneering biotech company using artificial intelligence and structural biology to develop innovative RNA-targeted therapeutics. Mark brings over 12 years of experience in biotechnology, with a proven track record of negotiating high-value partnerships and driving strategic collaborations in drug discovery.

00:00 Introduction to the Life Science Success Podcast
00:30 Meet Mark Stead: Journey into Life Sciences
03:26 Career Insights: From Amgen to Atomic AI
11:20 Innovations at Atomic AI: Leveraging AI and Structural Biology
19:37 The Future of AI in Drug Discovery
31:03 Leadership and Personal Insights
39:38 Conclusion and Farewell